TAVI Discussion

Dr Simon Kennon qualified from Manchester Medical School in 1992. He completed general medical training in and around London (Royal Free Hospital, Southend General Hospital, Newham General Hospital and the London Chest Hospital) before training in General and Interventional Cardiology at St Bartholomew’s and the London Chest Hospitals. His training continued with a fellowship in interventional cardiology at St Vincent's Hospital, Melbourne, Australia.

He was appointed as a Consultant Cardiologist in 2005. His NHS work is divided between the London Chest Hospital (Barts Health NHS Trust) and Barnet & Chase Farms Hospital NHS Trust.

His private practice is based at the King’s Oak Hospital, the Cavell Hospital and the London Independent Hospital.

Dr Kennon is experienced in the management of all general cardiology conditions (including palpitations, high blood pressure, and high cholesterol), but his special interests are the assessment…

Dr Byrne completed his undergraduate medical training in Bristol and then continued general professional medical training in the South-East of England and London.

He then undertook a PhD in the academic department of Cardiology at King’s College Hospital examining molecular mechanisms underlying left ventricular hypertrophy. Following completion he undertook his specialist training in Cardiology on the South Thames rotation. His training in interventional cardiology was undertaken at King’s College Hospital from 2004, and continued on Vancouver Island as a sponsored Interventional Fellow.

Dr Byrne is an editorial board member of Interventional Cardiology: Reviews, Research, Resources (ICR3).

Carlos E Ruiz is a professor of paediatrics and medicine and serves as the Director of the Congenital and Structural Heart Disease for the North Shore Long Island Jewish Health System and Lenox Hill Heart and Vascular Institute of New York. Dr Ruiz has authored more than 250 publications and has served as lead investigator in numerous national and international clinical studies. He pioneered the field of percutaneous mitral valvuloplasty, and was the first to describe the use of stents to maintain patency of the Ductus Arteriosus in the newborn with single ventricle physiology. More recently, with Drs Grube and Laborde, he pioneered the transcatheter aortic valve replacement using the self-expanding CoreValve prosthesis. As a national leader in education, Dr Ruiz was founder of the first Transcatheter Valve Symposium and serves as a Board member of EuroPCR. He has served for two terms as Trustee of the Society of Cardiac Angiography and Interventions and in numerous committees of…

Professor Lars Søndergaard is a consultant cardiologist at Rigshospitalet – Copenhagen, Denmark. Professor of Cardiology at University of Copenhagen, he published over 300 peer reviewed articles, and more than 15 textbook chapters. His research interests are focused on adults with congenital heart diseases and catheter-based heart valve interventions, as well as congenital and structural heart diseases. He led the first-in-human transcatheter mitral valve implantation (CardiAQ) in 2012 and he actively participated to several trials, including NOTION (transcatheter vs. surgical aortic valve replacement in patients with aortic stenosis and low surgical risk), and the REDUCE randomised trial (PFO vs anti-platelet therapy after cryptogenic stroke).

Prof Corrado Tamburino is full professor of Cardiology at the University of Catania, IT.  Director of the Cardiology Specialisation School and Head of Cardio-Thoraco-Vascular Department and Organ Transplant, Azienda Policlinico-Vittorio Emanuele, University of Catania.

He has published over 460 articles in journals and reported or moderated in over 460 national and international conferences. He has been attending the main international conferences of interventional cardiology as speaker and operator of live cases for years.

Operator of over 20,000 diagnostic and interventional procedures in hemodynamics with particular application in coronary angioplasty and stenting and in the treatment of heart valves diseases.

Prof Tamburino is an editorial board member of Interventional Cardiology: Reviews, Research, Resources (ICR3).

His interest spans complex coronary…